StockData
SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc. (SLS) stock

SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$19.15+11.68 (+156.36%)

Close on Nov 17, 2026Market cap $3.87BP/E –Yield –

SELLAS Life Sciences total assets

Total assets on the balance sheet at the end of each period.

SELLAS Life Sciences's total assets was $145.38M at Jun 30, 2026. For fiscal 2025 it was $78.35M, up 303.2% from the year before. Over ten years it grew -0.5% a year on average. The highest annual figure on record is $87.98M in fiscal 2013.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$78.35M+303.2%
FY2024Dec 31, 2024$19.43M+212.5%
FY2023Dec 31, 2023$6.22M-70.3%
FY2022Dec 31, 2022$20.94M-20.3%
FY2021Dec 31, 2021$26.28M-42.9%
FY2020Dec 31, 2020$46.05M+177.3%
FY2019Dec 31, 2019$16.61M-1.8%
FY2018Dec 31, 2018$16.92M-49.5%
FY2017Dec 31, 2017$33.53M+422.2%
FY2016Dec 31, 2016$6.42M-92.2%
FY2015Dec 31, 2015$82.14M+2.1%
FY2014Dec 31, 2014$80.49M-8.5%
FY2013Dec 31, 2013$87.98M+60.0%
FY2012Dec 31, 2012$54.99M+77.6%
FY2011Dec 31, 2011$30.97M+314.2%
FY2010Dec 31, 2010$7.48M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$145.38M+350.0%
Q1 FY2026Mar 31, 2026$114.18M+226.6%
Q4 FY2025Dec 31, 2025$78.35M+303.2%
Q3 FY2025Sep 30, 2025$51.56M+94.5%
Q2 FY2025Jun 30, 2025$32.31M+113.7%
Q1 FY2025Mar 31, 2025$34.96M+43.1%
Q4 FY2024Dec 31, 2024$19.43M+212.5%
Q3 FY2024Sep 30, 2024$26.51M+227.8%
Q2 FY2024Jun 30, 2024$15.12M-18.6%
Q1 FY2024Mar 31, 2024$24.43M-16.0%
Q4 FY2023Dec 31, 2023$6.22M-70.3%
Q3 FY2023Sep 30, 2023$8.09M-68.9%
Q2 FY2023Jun 30, 2023$18.57M-42.4%
Q1 FY2023Mar 31, 2023$29.10M+35.8%
Q4 FY2022Dec 31, 2022$20.94M-20.3%
Q3 FY2022Sep 30, 2022$26.00M-31.5%
Q2 FY2022Jun 30, 2022$32.21M-26.2%
Q1 FY2022Mar 31, 2022$21.43M-47.2%
Q4 FY2021Dec 31, 2021$26.28M-42.9%
Q3 FY2021Sep 30, 2021$37.95M+105.0%
Q2 FY2021Jun 30, 2021$43.62M+200.6%
Q1 FY2021Mar 31, 2021$40.58M+138.3%
Q4 FY2020Dec 31, 2020$46.05M+177.3%
Q3 FY2020Sep 30, 2020$18.51M-13.8%
Q2 FY2020Jun 30, 2020$14.51M-42.0%
Q1 FY2020Mar 31, 2020$17.03M+14.1%
Q4 FY2019Dec 31, 2019$16.61M-1.8%
Q3 FY2019Sep 30, 2019$21.48M-44.2%
Q2 FY2019Jun 30, 2019$25.03M-21.7%
Q1 FY2019Mar 31, 2019$14.93M-55.4%
Q4 FY2018Dec 31, 2018$16.92M-49.5%
Q3 FY2018Sep 30, 2018$38.47M-22.4%
Q2 FY2018Jun 30, 2018$31.97M-47.2%
Q1 FY2018Mar 31, 2018$33.49M-52.4%
Q4 FY2017Dec 31, 2017$33.53M+422.2%
Q3 FY2017Sep 30, 2017$49.60M-31.9%
Q2 FY2017Jun 30, 2017$60.55M–
Q1 FY2017Mar 31, 2017$70.33M–
Q4 FY2016Dec 31, 2016$6.42M–
Q3 FY2016Sep 30, 2016$72.85M–

More SELLAS Life Sciences figures

See a number that looks wrong?